Intellectual Property India Publishes Patent Application for 'Inhibitors Of Prostate Specific Membrane Antigen And Use Thereof' Filed by Shanghai Sinotau Biotech Co. Ltd.

MUMBAI, India, April 20 -- Intellectual Property India has published a patent application (202647043665 A) filed by Shanghai Sinotau Biotech Co. Ltd., Shanghai, on April 6, for 'inhibitors of prostate specific membrane antigen and use thereof.'

Inventor(s) include Jin, Yun; and Liu, Yang.

The application for the patent was published on April 17, under issue no. 16/2026.

According to the abstract released by the Intellectual Property India: "Provided herein are a compound of Formula (I), a pharmaceutical composition comprising said compound, and method of use of the compound or pharmaceutical composition in the diagnosis or treatment of a disease or disorder, e. g., a disease or disorder characterized by overexpression of prostate-specific membrane antigen (PSMA)."

The patent application was internationally filed on Sept. 11, 2024, under International application No.PCT/CN2024/118273.

Disclaimer: Curated by HT Syndication.